BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Selvaggi F, Catalano T, Cotellese R, Aceto GM. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents. Cancers 2022;14:1912. [DOI: 10.3390/cancers14081912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tabnak P, Ghasemi Y, Natami M, Khorram R, Ebrahimnezhad M. Role of m(6)A modification in dysregulation of Wnt/β-catenin pathway in cancer. Biomed Pharmacother 2023;157:114023. [PMID: 36403567 DOI: 10.1016/j.biopha.2022.114023] [Reference Citation Analysis]
2 Gulati R, Hanlon MA, Lutz M, Quitmeyer T, Geller J, Tiao G, Timchenko L, Timchenko N. Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma. Cancers (Basel) 2022;14. [PMID: 36551548 DOI: 10.3390/cancers14246062] [Reference Citation Analysis]
3 Leung RWH, Lee TKW. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 2022;14:5468. [DOI: 10.3390/cancers14215468] [Reference Citation Analysis]
4 Papoutsoglou P, Louis C, Pineau R, L’haridon A, Banales JM, Gilot D, Aubry M, Coulouarn C. TGFβ-induced long non-coding RNA LINC00313 activates Wnt signalling and promotes cholangiocarcinoma progression.. [DOI: 10.21203/rs.3.rs-1967984/v1] [Reference Citation Analysis]